Thursday, 28 February 2019

Big Bristol-Myers Shareholder Opposes Celgene Deal

One of Bristol-Myers’s largest shareholders is opposing the company’s $74 billion deal to buy rival Celgene, becoming the latest investor to express its unhappiness with the transaction.

from WSJ.com: US Business https://ift.tt/2Vp3T2t

No comments:

Post a Comment

Ford's $30,000 EV truck is under wraps. Its camouflage is an ad.

Ford's all-important EV pickup truck has donned camouflage during public outings. The sneaky attire includes a QR for a hidden website l...